Hasil Pencarian - Elizabeth Buchbinder

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders

    Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders oleh Hillard M. Lazarus, Katherine Pitts, Tisha Wang, Elinor Lee, Elizabeth Buchbinder, Elizabeth Buchbinder, Elizabeth Buchbinder, Michael Dougan, Michael Dougan, Michael Dougan, David G. Armstrong, Robert Paine, Carolyn E. Ragsdale, Timothy Boyd, Edwin P. Rock, Robert Peter Gale

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Checkpoint inhibitor induced esophagitis with documented resolution on infliximab

    Checkpoint inhibitor induced esophagitis with documented resolution on infliximab oleh Frank W. Chen, Anne F. Liu, Amitabh Srivastava, Elizabeth Buchbinder, Shilpa Grover

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

    304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in a... oleh Kim Margolin, Antoni Ribas, Riyue Bao, Adil Daud, Mohammed Milhem, Elizabeth Buchbinder, Geoffrey Gibney, Jason Luke, Takami Sato, David Mauro, Yousef Zakharia, Theresa Medina, John Kirkwood, Jiaxin Niu, Katie Campbell, George Weiner, Inderjit Mehmi, Heather Kelley, James Wooldridge

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma

    950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melano... oleh Hong Liu, Kim Margolin, Antoni Ribas, Adil Daud, Mohammed Milhem, Elizabeth Buchbinder, Geoffrey Gibney, Jason Luke, Diwakar Davar, Takami Sato, Bartosz Chmielowski, Luping Zhao, Yousef Zakharia, Theresa Medina, John Kirkwood, Jiaxin Niu, Anthony Olszanski, Montaser Shaheen, George Weiner, Arthur Krieg, Inderjit Mehmi, Heather Kelley, James Wooldridge, Dmitri Bobilev

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: